{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:28:06Z","timestamp":1793982486202,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.semcancer.2021.07.016","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T12:46:00Z","timestamp":1627562760000},"page":"923-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"P2","title":["Association of Chlamydia and Mycoplasma infections with susceptibility to ovarian cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"86","author":[{"given":"Seyed-Abolfazl","family":"Hosseininasab-nodoushan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Ghazvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Keikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"S1","key":"10.1016\/j.semcancer.2021.07.016_bib0010","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1472-6874-4-S1-S14","article-title":"Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers","volume":"4","author":"Duarte-Franco","year":"2004","journal-title":"BMC Women\u2019s Health"},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.016_bib0015","first-page":"415","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis","volume":"28","author":"Zhou","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.016_bib0020","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0002-9378(80)91100-X","article-title":"Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction: Chlamydia trachomatis and Ureaplasma urealyticum","volume":"138","author":"Henry-Suchet","year":"1980","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QCO.0b013e3282f3d9ac","article-title":"Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease","volume":"21","author":"Haggerty","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.016_bib0030","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/sti.75.1.21","article-title":"Pathogenesis of Chlamydia induced pelvic inflammatory disease","volume":"75","author":"Cohen","year":"1999","journal-title":"Sex. Transm. Infect."},{"issue":"21","key":"10.1016\/j.semcancer.2021.07.016_bib0040","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.016_bib0045","first-page":"793","article-title":"Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment","volume":"27","author":"Mitchell","year":"2013","journal-title":"Infect. Dis. Clin."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.016_bib0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.22325","article-title":"Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors","volume":"120","author":"Madeleine","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A","article-title":"Chlamydia trachomatis infection as a risk factor for invasive cervical cancer","volume":"85","author":"Koskela","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.285.1.47","article-title":"Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma","volume":"285","author":"Anttila","year":"2001","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.016_bib0065","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.semcancer.2021.07.016_bib0070","series-title":"Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates","author":"Organization WH","year":"2001"},{"issue":"668","key":"10.1016\/j.semcancer.2021.07.016_bib0075","first-page":"1926","article-title":"Chlamydia trachomatis infection\u2019s eradication: a daily goal","volume":"15","author":"Grouzmann","year":"2019","journal-title":"Rev. Med. Suisse"},{"key":"10.1016\/j.semcancer.2021.07.016_bib0080","series-title":"How Can We Eradicate Chlamydia?","author":"Rousser","year":"2017"},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.016_bib0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-3804(05)80092-1","article-title":"Association of positive Chlamydia trachomatis and Chlamydia pneumoniae immunoglobulin-\u03b3 titers with increasing age","volume":"4","author":"Martin","year":"1997","journal-title":"J. Am. Assoc. Gynecol. Laparosc."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1996.0316","article-title":"Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR\u2013ELISA","volume":"63","author":"Chan","year":"1996","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajog.2009.07.042","article-title":"Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions","volume":"202","author":"Idahl","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.016_bib0100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1006\/gyno.2001.6446","article-title":"Detection of Mycoplasma ribosomal DNA sequences in ovarian tumors by nested PCR","volume":"83","author":"Quirk","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0105","first-page":"18","article-title":"Prevalence of chlamydia trachomatis and mycoplasma genitalium in patients with benign and malignant ovarian cancer by nested PCR method","volume":"4","author":"Dadashi","year":"2016","journal-title":"Nov. Biomed."},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.016_bib0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11805-010-0534-8","article-title":"Detection of Mycoplasma hyorhinis infection in ovarian cancer with in situ hybridization and immunohistochemistry","volume":"7","author":"Yang","year":"2010","journal-title":"Clin. Oncol. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djy084","article-title":"Antibodies against Chlamydia trachomatis and ovarian cancer risk in two independent populations","volume":"111","author":"Trabert","year":"2019","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.016_bib0120","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","article-title":"Viral and bacterial aetiologies of epithelial ovarian cancer","volume":"31","author":"Shanmughapriya","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.semcancer.2021.07.016_bib0125","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.016_bib0130","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32999","article-title":"Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort","volume":"147","author":"Idahl","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2021.07.016_bib0135","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tranon.2018.02.008","article-title":"Chlamydia trachomatis, chlamydial heat shock protein 60 and anti-chlamydial antibodies in women with epithelial ovarian tumors","volume":"11","author":"Jonsson","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.semcancer.2021.07.016_bib0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/IJWH.S188938","article-title":"Chlamydia trachomatis infection in primary fallopian tube and high-grade serous ovarian cancers: a pilot study","volume":"11","author":"Laban","year":"2019","journal-title":"Int. J. Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tranon.2019.09.007","article-title":"Chlamydia trachomatis and anti-MUC1 serology and subsequent risk of high-grade serous ovarian cancer: a population-based case\u2013control study in Northern Sweden","volume":"13","author":"Jonsson","year":"2020","journal-title":"Transl. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.016_bib0155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41416-019-0422-9","article-title":"Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses\u2019 Health Studies","volume":"120","author":"Fortner","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.016_bib0160","first-page":"2433","article-title":"Frequency of germline and somatic BRCA1 mutations in ovarian cancer","volume":"4","author":"Berchuck","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.016_bib0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrmicro1130","article-title":"Bacterial toxins and cancer\u2014a case to answer?","volume":"3","author":"Lax","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0170","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12766","article-title":"A comparative whole genome analysis of Helicobacter pylori from a human dense South Asian setting","volume":"26","author":"Qumar","year":"2021","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.016_bib0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpedi.161.3.246","article-title":"Burden of recurrent Chlamydia trachomatis infections in young women: further uncovering the \u201chidden epidemic\u201d","volume":"161","author":"Niccolai","year":"2007","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.016_bib0180","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jdv.13850","article-title":"Background review for the 2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.016_bib0185","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jdv.13849","article-title":"2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S2237-93632012000100003","article-title":"Coinfection of Epstein-Barr virus, cytomegalovirus, herpes simplex virus, human papillomavirus and anal intraepithelial neoplasia in HIV patients in Amazon, Brazil","volume":"32","author":"Guimar\u00e3es","year":"2012","journal-title":"J. Coloproctol. (Rio de Janeiro)"},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.016_bib0195","first-page":"1521","article-title":"Viral infections as a cause of cancer","volume":"30","author":"Carrillo-Infante","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-35","article-title":"\u2019The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women\u2019","volume":"11","author":"Walker","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2021.07.016_bib0205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.CIR.100.8.832","article-title":"Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis","volume":"100","author":"Markus","year":"1999","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.016_bib0210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/apm.12430","article-title":"Evaluation of the new AmpliSens multiplex real\u2010time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis","volume":"123","author":"Rumyantseva","year":"2015","journal-title":"Apmis"},{"issue":"33","key":"10.1016\/j.semcancer.2021.07.016_bib0215","doi-asserted-by":"crossref","first-page":"20560","DOI":"10.2807\/1560-7917.ES2013.18.33.20560","article-title":"Increase in gonorrhoea among very young adolescents, Catalonia, Spain, January 2012 to June 2013","volume":"18","author":"Vives","year":"2013","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajcp\/85.1.89","article-title":"Detection of Chlamydia trachomatis in genital specimens by the MicrotrakTM direct specimen test","volume":"85","author":"Coudron","year":"1986","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0225","first-page":"65","article-title":"Pooling of urine samples for molecular detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium as a screening strategy among young adults in Catalonia","volume":"38","author":"L\u00f3pez-Corbeto","year":"2020","journal-title":"Enfermedades infecciosas y microbiologia clinica (English ed)"},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.016_bib0230","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2105\/AJPH.2005.074062","article-title":"Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection","volume":"97","author":"Manhart","year":"2007","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.016_bib0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/sti.2006.022970","article-title":"Mycoplasma genitalium: prevalence and behavioural risk factors in the general population","volume":"83","author":"Andersen","year":"2007","journal-title":"Sex. Transm. Infect."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01717455","article-title":"Prevalence of genital chlamydia and mycoplasma infection in couples attending a male infertility clinic","volume":"10","author":"Samra","year":"1994","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2021.07.016_bib0245","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/183167","article-title":"Chlamydia trachomatis and genital mycoplasmas: pathogens with an impact on human reproductive health","volume":"2014","author":"Ljubin-Sternak","year":"2014","journal-title":"J. Pathog."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0250","first-page":"1","article-title":"Mycoplasma and Chlamydia infection can increase risk of endometrial cancer by pro-inflammatory cytokine enlargement","volume":"19","author":"Gunin","year":"2021","journal-title":"Indian J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2164\/jandrol.107.003566","article-title":"Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples","volume":"29","author":"Gdoura","year":"2008","journal-title":"J. Androl."},{"issue":"3","key":"10.1016\/j.semcancer.2021.07.016_bib0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mimet.2012.03.009","article-title":"The first performance report for the Bio-Rad Dx CT\/NG\/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples","volume":"89","author":"Le Roy","year":"2012","journal-title":"J. Microbiol. Methods"},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.016_bib0265","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/sti.2010.042598","article-title":"Alarmingly poor performance in Chlamydia trachomatis point-of-care testing","volume":"86","author":"van Dommelen","year":"2010","journal-title":"Sex. Transm. Infect."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.016_bib0270","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/humrep\/dez169","article-title":"Detection of chlamydia infection within human testicular biopsies","volume":"34","author":"Bryan","year":"2019","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.semcancer.2021.07.016_bib0275","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/sj.jid.5700888","article-title":"Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry","volume":"127","author":"Buffet","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.07.016_bib0280","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bpobgyn.2006.06.003","article-title":"A review on infection with Chlamydia trachomatis","volume":"20","author":"Manavi","year":"2006","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.07.016_bib0285","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/IAI.69.4.2442-2447.2001","article-title":"Persistent Chlamydia trachomatisinfections resist apoptotic stimuli","volume":"69","author":"Dean","year":"2001","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.semcancer.2021.07.016_bib0290","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","article-title":"Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro","volume":"90","author":"Beatty","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00018-004-4367-6","article-title":"Is chlamydial heat shock protein 60 a risk factor for oncogenesis?","volume":"62","author":"Di Felice","year":"2005","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"5","key":"10.1016\/j.semcancer.2021.07.016_bib0300","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/IAI.70.5.2605-2613.2002","article-title":"Chlamydia trachomatis disrupts N-cadherin-dependent cell-cell junctions and sequesters \u03b2-catenin in human cervical epithelial cells","volume":"70","author":"Prozialeck","year":"2002","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.semcancer.2021.07.016_bib0305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0956462413515196","article-title":"Mycoplasma genitalium: a review","volume":"25","author":"Daley","year":"2014","journal-title":"Int. J. STD AIDS"},{"issue":"2","key":"10.1016\/j.semcancer.2021.07.016_bib0310","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3748\/wjg.v7.i2.266","article-title":"Mycoplasma infections and different human carcinomas","volume":"7","author":"Huang","year":"2001","journal-title":"World J. Gastroenterol."},{"issue":"22","key":"10.1016\/j.semcancer.2021.07.016_bib0315","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1073\/pnas.92.22.10197","article-title":"Lo S-C. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation","volume":"92","author":"Tsai","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.semcancer.2021.07.016_bib0320","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0003-9861(90)90552-A","article-title":"Evidence for superoxide dismutase and catalase in mollicutes and release of reactive oxygen species","volume":"277","author":"Meier","year":"1990","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21002042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21002042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:27:27Z","timestamp":1760920047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X21002042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":64,"alternative-id":["S1044579X21002042"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.016","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Chlamydia and Mycoplasma infections with susceptibility to ovarian cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}